Silk Fibroin/PLA 3D Printed Composite Stent Fabricated through Direct Ink Write Technology

Abstract:

Bioresorbable alternatives are emerging on the market as alternatives to the cardiovascular stents that are implanted nowadays. Permanent drug-eluting stents are no longer the only viable option during an angioplasty surgical procedure. The new generation of medical stents aims to degrade the device within the artery walls after its function has been completed. In this context, biological materials that degrade inside the body without creating toxic residues such as silk fibroin (SF) are very promising materials for such applications. Moreover, SF has been reported to have non-thrombogenic properties and to reduce the immune response compared to other synthetic polymers, making it ideal for this application. SF has been printed through additive manufacturing techniques such as direct ink write. This study proposes to fabricate a composite stent by combining polylactic acid (PLA) and SF. In this way, it is expected to obtain a stent with potential for a two-phase drug release. A fast burst with the degradation of the SF and a slower drug release period with the degradation of the PLA. For this purpose, stents were fabricated with a PLA and chloroform ink (24.5 % w/v). The last layer of the stent was fabricated with a SF water-based ink at 56.69-60.09 % w/w. Finally, the stents were immersed at different times in ethanol and exposed to 30' of ultraviolet light for sterilization purposes. The degradation results indicate that 24h is sufficient to degrade almost completely the last layer of SF. These results are significant as the SF layer could potentially be used as a carrier for drug delivery, providing biocompatibility and drug release at the earliest post-intervention stage.

• Periodical: Key Engineering Materials (Volume 956)
• Pages: 3-11
• DOI: https://doi.org/10.4028/p-uR8a5S
• Online since: September 2023
• Authors: Enric Casanova-Batlle, Aniol Bosch, Antonio J. Guerra, Joaquim Ciurana*
• Keywords: Additive Manufacturing, Cardiovascular Stent, Ink, Silk Fibroin

References

[1] S. Commandeur, H.M.M. Van Beusekom, W.J. Van Der Giessen, Polymers, drug release, and drug-eluting stents, J. Interv. Cardiol. 19 (2006) 500–506.

DOI: 10.1111/J.1540-8183.2006.00198.X

[2] P.W. Serruys, E. Regar, A.J. Carter, Rapamycin eluting stent: the onset of a new era in interventional cardiology, Heart. 87 (2002) 305.

DOI: 10.1136/HEART.87.4.305

[3] A. Colombo, J. Drzewiecki, A. Banning, E. Grube, K. Hauptmann, S. Silber, D. Dudek, S. Fort, F. Schiele, K. Zmudka, G. Guagliumi, M.E. Russell, Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions, Circulation. 108 (2003) 788–794.

DOI: 10.1161/01.CIR.0000086926.62288.A6

[4] F. Bozsak, D. Gonzalez-Rodriguez, Z. Sternberger, P. Belitz, T. Bewley, J.M. Chomaz, A.I. Barakat, Optimization of Drug Delivery by Drug-Eluting Stents, PLoS One. 10 (2015) e0130182.

DOI: 10.1371/JOURNAL.PONE.0130182

[5] P.W. Serruys, M.J.B. Kutryk, A.T.L. Ong, Coronary-Artery Stents, Https://Doi.Org/10.1056/NEJMra051091. 354 (2006) 483–495.

DOI: 10.1056/NEJMRA051091

[6] E. Wenk, H.P. Merkle, L. Meinel, Silk fibroin as a vehicle for drug delivery applications, J. Control. Release. 150 (2011) 128–141.

DOI: 10.1016/J.JCONREL.2010.11.007

[7] L. Meinel, S. Hofmann, V. Karageorgiou, C. Kirker-Head, J. McCool, G. Gronowicz, L. Zichner, R. Langer, G. Vunjak-Novakovic, D.L. Kaplan, The inflammatory responses to silk films in vitro and in vivo, Biomaterials. 26 (2005) 147–155.

DOI: 10.1016/J.BIOMATERIALS.2004.02.047

[8] E.M. Pritchard, D.L. Kaplan, Silk fibroin biomaterials for controlled release drug delivery, Http://Dx.Doi.Org/10.1517/17425247.2011.568936. 8 (2011) 797–811.

DOI: 10.1517/17425247.2011.568936

[9] J. Wiebe, P. Hoppmann, R. Colleran, S. Kufner, M. Valeskini, S. Cassese, S. Schneider, M. Joner, H. Schunkert, K.L. Laugwitz, A. Kastrati, R.A. Byrne, Long-Term Clinical Outcomes of Patients Treated With Everolimus-Eluting Bioresorbable Stents in Routine Practice: 2-Year Results of the ISAR-ABSORB Registry, JACC Cardiovasc. Interv. 10 (2017) 1222–1229.

DOI: 10.1016/j.jcin.2017.03.029

[10] A.J. Guerra, P. Cano, M. Rabionet, T. Puig, J. Ciurana, 3D-Printed PCL/PLA Composite Stents: Towards a New Solution to Cardiovascular Problems, Mater. (Basel, Switzerland). 11 (2018).

DOI: 10.3390/MA11091679

[11] V. Chausse, R. Schieber, Y. Raymond, B. Ségry, R. Sabaté, K. Kolandaivelu, M.-P. Ginebra, M. Pegueroles, Solvent-cast direct-writing as a fabrication strategy for radiopaque stents, Addit. Manuf. 48 (2021) 102392.

DOI: 10.1016/J.ADDMA.2021.102392

[12] E. Casanova-Batlle, A.J. Guerra, J. Ciurana, Characterization of direct ink write pure silk fibroin based on alcohol post-treatments, Polym. Test. 116 (2022) 107784.

DOI: 10.1016/J.POLYMERTESTING.2022.107784

[13] S.H. Kim, D.Y. Kim, T.H. Lim, C.H. Park, Silk Fibroin Bioinks for Digital Light Processing (DLP) 3D Bioprinting, Adv. Exp. Med. Biol. 1249 (2020) 53–66.

DOI: 10.1007/978-981-15-3258-0_4

[14] D. da Silva, M. Kaduri, M. Poley, O. Adir, N. Krinsky, J. Shainsky-Roitman, A. Schroeder, Biocompatibility, biodegradation and excretion of polylactic acid (PLA) in medical implants and theranostic systems, Chem. Eng. J. 340 (2018) 9.

DOI: 10.1016/J.CEJ.2018.01.010

[15] A.J. Guerra, P. Cano, M. Rabionet, T. Puig, J. Ciurana, Effects of different sterilization processes on the properties of a novel 3D-printed polycaprolactone stent, Polym. Adv. Technol. 29 (2018) 2327–2335.

DOI: 10.1002/PAT.4344

[16] A. Guerra, A. Roca, J. Ciurana, A novel 3D additive manufacturing machine to biodegradable stents, Procedia Manuf. 13 (2017) 718–723.

DOI: 10.1016/j.promfg.2017.09.118

[17] D.N. Rockwood, R.C. Preda, T. Yücel, X. Wang, M.L. Lovett, D.L. Kaplan, Materials fabrication from Bombyx mori silk fibroin, Nat. Protoc. 6 (2011) 1612–1631.

DOI: 10.1038/nprot.2011.379

[18] M.A. de Moraes, G.M. Nogueira, R.F. Weska, M.M. Beppu, Preparation and Characterization of Insoluble Silk Fibroin/Chitosan Blend Films, Polym. 2010, Vol. 2, Pages 719-727. 2 (2010) 719–727.

DOI: 10.3390/POLYM2040719

[19] Y. Cao, B. Wang, Biodegradation of Silk Biomaterials, Int. J. Mol. Sci. 10 (2009) 1514.

DOI: 10.3390/IJMS10041514

[20] Q. Lu, B. Zhang, M. Li, B. Zuo, D.L. Kaplan, Y. Huang, H. Zhu, Degradation mechanism and control of silk fibroin, Biomacromolecules. 12 (2011) 1080–1086.

DOI: 10.1021/bm101422j

[21] M. Puerta, M.C. Arango, N. Jaramillo-Quiceno, C. Álvarez-López, A. Restrepo-Osorio, Influence of ethanol post-treatments on the properties of silk protein materials, SN Appl. Sci. 1 (2019) 1–7.

DOI: 10.1007/s42452-019-1486-0